BRIEF published on 07/22/2026 at 16:01, 1 month 21 days ago Vanguard Group's Position in Rotork plc at 5.43% Takeover Code Securities Disclosure Vanguard Group Shareholding Rotork Plc
BRIEF published on 07/22/2026 at 16:00, 1 month 21 days ago The Vanguard Group Discloses Major Stake in Schroders PLC Form 8.3 Takeover Code Schroders Plc Vanguard Group Investment Disclosure
PRESS RELEASE published on 07/22/2026 at 15:59, 1 month 21 days ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc. The Vanguard Group, Inc. discloses a 13.57% stake in Prologis, Inc. as of 21 July 2026. Additional disclosures made for SEGRO plc. Transactions include purchases and sales of USD 0.01 common stock Transactions Disclosure Vanguard Group Stake Prologis Inc.
BRIEF published on 07/22/2026 at 15:58, 1 month 21 days ago The Vanguard Group Discloses Interest in SEGRO plc Takeover Code Vanguard Group Financial Disclosure Shareholding SEGRO PLC
PRESS RELEASE published on 07/22/2026 at 15:57, 1 month 21 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 4.99% interest in Beazley plc's 5p ordinary shares as of 21 July 2026. Details in Form 8.3 filing Disclosure Vanguard Group Form 8.3 Filing 5p Ordinary Shares Beazley Plc
PRESS RELEASE published on 07/22/2026 at 15:56, 1 month 21 days ago Form 8.3 - The Vanguard Group, Inc.: Rotork plc The Vanguard Group, Inc. discloses a 5.43% interest in Rotork plc's 0.5p ordinary shares. Details in accordance with UK Takeover Code Rule 8.3 The Vanguard Group Rule 8.3 Interest Disclosure UK Takeover Code Rotork Plc
PRESS RELEASE published on 07/22/2026 at 15:55, 1 month 21 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.71% stake in Schroders plc through Form 8.3 under Takeover Code on 21 July 2026 Form 8.3 The Vanguard Group Takeover Code Schroders Plc Stake Disclosure
PRESS RELEASE published on 07/22/2026 at 15:53, 1 month 21 days ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses 5.64% stake in SEGRO plc. Purchased 10p ordinary shares at 8.69 & 8.85 GBP per unit on 21 July 2026 Vanguard Group Stake Disclosure 10p Ordinary Shares Purchase Transactions SEGRO PLC
BRIEF published on 07/21/2026 at 15:54, 1 month 22 days ago Vanguard Group Discloses Stake in Tate & Lyle Form 8.3 Takeover Code Vanguard Group Stock Disclosure Tate & Lyle
BRIEF published on 07/21/2026 at 15:53, 1 month 22 days ago Vanguard Discloses Position in Spire Healthcare Group plc Form 8.3 Takeover Code Vanguard Group Spire Healthcare Stake Disclosure
Published on 09/12/2026 at 02:35, 14 hours 51 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 18 hours 26 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 19 hours 21 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 20 hours 1 minute ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 9 hours 55 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 19 hours 11 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 19 hours 15 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 21 hours 41 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 23 hours 10 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 10 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 21 hours ago Availability of the 2026 Interim Financial Report
